iRhythm Holdings (IRTC) Q2 FY26 earnings call

iRhythm delivered a robust second quarter, driven by sustained demand for Zio products and strong commercial execution across all channels. The strategic acquisition of Vital Connect is set to expand the company's cardiac monitoring capabilities, particularly in the MCT market and into new areas like multivital and inpatient monitoring. Management remains focused on balancing profitable growth with strategic investments in innovation and market expansion, while addressing regulatory and operational challenges.